Home » Topics » Disease categories and therapies » Immune

Immune
RSS

North American lung transplant program under way for ATG-Fresenius S

Jan. 17, 2005

Rotarix launched in Mexico

Jan. 11, 2005

Topline results of phase III orBec study

Jan. 11, 2005

ACAM-2000 smallpox vaccine granted fast track designation

Jan. 10, 2005

Scientists at Kyorin prepare and test a series of immunosuppressants

Jan. 4, 2005

Octagam approved in Australia

Dec. 27, 2004

Inhibition of poly(ADP-ribose) synthase increases cardiac allograft survival

Dec. 23, 2004

Add-on Uvadex therapy reported to improve outcome in patients receiving ASCT

Dec. 23, 2004

Fast track status for AMG-531 in immune thrombocytopenic purpura

Dec. 10, 2004

Phase II data on the effects and safety of aselizumab in patients with multiple trauma

Dec. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...